Stryker Rejuvenate ABGII Hip Implant Settlements

On December 19, 2016, a second global settlement involving Stryker’s Rejuvenate and ABGII hip implants was reached. Stryker and plaintiffs’ counsel resolved claims on behalf of patients who were injured from the failed Rejuvenate and ABGII hip implants.

The settlement provides for gross base awards of $300,000 per failed implant and for significant additional compensation for claimants who suffered complications during and after their revision surgery. The settlement also provides compensation for individuals who need a revision but are medically unable to undergo the surgery. Claimants are expected to begin receiving their awards by the early Fall of 2017.